# Evaluation of the Fluoride Dose Response Using In Situ Caries Model

> **NCT04763044** · PHASE4 · COMPLETED · sponsor: **Procter and Gamble** · enrollment: 15 (actual)

## Conditions studied

- Caries

## Interventions

- **DRUG:** 0 ppm F
- **DRUG:** 250 ppm F as MFP
- **DRUG:** 1100 ppm as MFP
- **DRUG:** 2800 ppm F as MFP
- **DRUG:** 1100 ppm SnF2

## Key facts

- **NCT ID:** NCT04763044
- **Lead sponsor:** Procter and Gamble
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-01
- **Primary completion:** 2021-07-21
- **Final completion:** 2021-07-21
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2022-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04763044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04763044, "Evaluation of the Fluoride Dose Response Using In Situ Caries Model". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04763044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*